TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›HMN
HMN logo

HMN

HORACE MANN EDUCATORS CORP /DE/

Next earnings Aug 4, 2026 · consensus $0.70 EPS, $448M rev

Last earnings -0.7% on 2026-05-06

Buy
$53.85
▲ +3.44%
$53.85▲ +29.51%
over 1Y
L $38.94H $53.85
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.4%
1W+6.3%
1M+17.8%
3M+25.5%
YTD+21.1%
1Y+29.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
A-
Valuation
Undervalued
Filings
Clean
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 7 analysts
Buy

Cheap, recovering educator-focused insurer: 13.3x earnings, 1.4x book, EPS +57% and operating cash flow surging.

Diluted EPS $3.90 · FY2025

The read

Quality fundamentals and an attractive price line up (~175% below fair value) — the rarer case where both the business and the entry look good.

Horace Mann is a multiline insurer to the education niche that has clearly turned the corner after a rough patch. Net income has climbed from a $19.8M trough in FY2022 to $45M (2023), $103M (2024) and $162M in FY2025 (+57.7%), with diluted EPS up 57.3% to $3.90. Revenue has compounded steadily ($1.33B→$1.70B since 2021), but the real story is normalization of profitability — net margin recovered to 9.5% and ROE to 10.9%. Operating cash flow of $553M (+22.4%) is roughly 3.4x net income, underscoring that earnings are cash-backed and that the insurance subsidiaries throw off cash 'generally well in excess' of policy obligations per the MD&A.

The MD&A explains the earnings inflection: management states that 'because of the annuity reinsurance transaction, the spread in our retained annuity business is achieving our targeted returns.' Removing the drag from the legacy annuity spread is precisely what should make the post-2022 recovery durable rather than a one-off. Capital management is disciplined — equity grew 15.2% to $1.48B, dividends paid rose to $57.1M (~2.7% yield), and the September 2025 refinancing replaced $250M of 4.50% notes with $300M of 4.70% notes due 2030, clearing near-term maturity risk (current portion of debt is $0). Long-term debt of $593M against $1.48B equity is modest for an insurer; the 9.3x liabilities/equity ratio is mostly policyholder reserves, not leverage.

Is HMN a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.33B$1.38B$1.49B$1.60B$1.70B
Gross profit—————
Operating income—————
Net income$170M$19.8M$45.0M$103M$162M
Diluted EPS$4.04$0.47$1.09$2.48$3.90
Net margin12.8%1.4%3.0%6.4%9.5%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)0.24
Earnings yield7.5%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt$593M
Net cash-$566M
Piotroski F-Score6/7

Capital returns

Buyback yield0.1%
Dividend yield (est.)2.6%
Shareholder yield2.7%
Shares Δ YoY-1.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Shareholder vote2026-05-21

    Annual meeting voting results filed; routine director/proposal outcomes, no financial impact

  2. 10-Q Quarterly report2026-05-08

    Q1 2026 (period 3/31): continued momentum off record FY2025 results

  3. 8-K Earnings results2026-05-06

    Q1 2026 earnings release issued amid record FY2025 earnings momentum

  4. DEF 14A Proxy statement2026-04-06

    2026 proxy: board, exec comp and AGM proposals; governance routine

  5. 8-K Officer / director change2026-03-27

    Officer/director change disclosed; leadership transition, no immediate financial effect

  6. 10-K Annual report2026-02-27

    FY2025: revenue $1.70B (+7%), net income $162M (+58%), equity +15%, OCF $553M

  7. 8-K Earnings results2026-02-03

    Q4/FY2025 earnings: net income +58% to $162M, EPS $3.90

  8. 10-Q Quarterly report2025-11-07

    Q3 2025: profit recovery continuing as P&C margins and investment income improve

  9. 8-K Earnings results2025-11-04

    Q3 2025 earnings release; on track for record full-year profit

Recent filings

all on EDGAR ↗
4Period ending 2026-07-012026-07-02open ↗144Filing2026-07-01open ↗4Period ending 2026-06-242026-06-26open ↗4Period ending 2026-06-022026-06-04open ↗144Filing2026-06-02open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗4Period ending 2026-05-202026-05-22open ↗

Quality score

A-
ValueGrowthProfitHealthMom.
ValueA
GrowthA-
ProfitabilityB-
Financial healthA-
MomentumA+
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$148.20

Undervalued +175% vs price

cheapfair valueexpensive

Modified Graham: EPS $3.90 × (8.5 + 1.5 × 22.0% growth) × 1.00 quality = 38.0× multiple. An estimate, not a price target.

38.9452-week53.85
Revenue
$1.70B
+6.7% YoY
Net margin
9.5%
ROE
10.9%
P/E
13.8

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.70B+6.7%
Net income$162M+57.7%
Diluted EPS$3.90+57.3%
Cash & equivalents$27.5M-27.8%
Total assets$15.3B+5.4%
Total liabilities$13.8B+4.4%
Stockholders' equity$1.48B+15.2%
L/E: 9.30x

Frequently asked

Is HORACE MANN EDUCATORS CORP /DE/ (HMN) a buy?
HMN currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. Cheap, recovering educator-focused insurer: 13.3x earnings, 1.4x book, EPS +57% and operating cash flow surging.
What is HMN's fair value?
A Modified-Graham model based on HMN's SEC fundamentals estimates a fair value of about $148.20. It is an estimate from reported earnings, not a price target.
Is HMN overvalued or undervalued?
Against a Modified-Graham fair-value estimate, HMN currently appears undervalued relative to its SEC-grounded earnings power.
What is HORACE MANN EDUCATORS CORP /DE/'s quality score?
HMN scores 80.04075105647331/100 (grade A-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000850141, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/30/2026, 4:33:46 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 12:33 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 2 sales

2026-07-01
ZURAITIS MARITA
President & CEO
Sell7.50K @ $52.62$395K
2026-06-24
ZURAITIS MARITA
President & CEO
Exercise70.4K @ $41.95$2.95M
2026-06-24
ZURAITIS MARITA
President & CEO
Tax63.7K @ $50.75$3.23M
2026-06-24
ZURAITIS MARITA
President & CEO
Exercise71.5K @ $42.95$3.07M
2026-06-24
ZURAITIS MARITA
President & CEO
Tax65.5K @ $50.75$3.32M
2026-06-02
ZURAITIS MARITA
President & CEO
Sell7.50K @ $46.25$347K
2026-05-20
Samuel Aaliyah A
Director
Award2.78K @ $46.77$130K
2026-05-20
Fetter Victor
Director
Award2.78K @ $46.77$130K
2026-05-20
Fetter Victor
Director
Award1.18K @ $46.77$55.0K
2026-05-20
Sarsynski Elaine A
Director
Award2.78K @ $46.77$130K
2026-05-20
Reece Henry Wade
Director
Award2.78K @ $46.77$130K
2026-05-20
McClure Beverley J.
Director
Award2.78K @ $46.77$130K

Dividends

Quarterly
Yield (TTM)
2.6%
Annual / share
$1.42
Last ex-date
2026-06-15
Last amount
$0.36
ex 2026-06-15paid 2026-06-30$0.36
ex 2026-03-17paid 2026-03-31$0.36
ex 2025-12-15paid 2025-12-31$0.35
ex 2025-09-16paid 2025-09-30$0.35
ex 2025-06-16paid 2025-06-30$0.35
ex 2025-03-17paid 2025-03-31$0.35

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-06Beat +16.3% est▼ -0.70%8-K ↗
2026-02-03Beat +1.7% est▲ +0.09%8-K ↗
2025-11-04Beat +21.0% est▲ +2.24%8-K ↗
2025-08-06Beat +76.1% est▲ +0.67%8-K ↗
2025-05-06—▼ -1.44%8-K ↗
2025-02-05—▲ +1.92%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

1 sell · 1 member · last 180d

−$8.00K net soldlast trade 181d ago
$0.00 bought$8.00K sold
2026-02-13Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainBuy$1.00K–$15.0KPTR ↗
2025-05-14Josh GottheimerSell$1.00K–$15.0KPTR ↗
2023-08-21Josh GottheimerBuy$1.00K–$15.0KPTR ↗
2023-07-11Josh GottheimerSell$1.00K–$15.0KPTR ↗
2020-11-05Josh GottheimerBuy$1.00K–$15.0KPTR ↗
2020-10-13Josh GottheimerSell$1.00K–$15.0KPTR ↗
2020-09-14Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2020-06-16Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2020-04-16Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2020-03-16Josh GottheimerBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score80 vs 67
Revenue growth6.7% vs 7.5%
Net margin9.5% vs 10.0%
Return on equity10.9% vs 12.0%
P/E13.8 vs 26.2

News sentiment

EODHD · 16d
Bullish
+0.18
vs typical · 21 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.